SOURCE: annual_report_text (1).txt
CHUNK: 83 of 1106
SIZE: 600 characters
PREVIOUS: chunk_0082_annual_report_text (1).txt
NEXT: chunk_0084_annual_report_text (1).txt
------------------------------
ed in the trial. A total of 
approximately 400 patients are expected to be included 
in the randomized trial with study completion planned 
for 2027. It is hoped that the trial will produce high-quality data, which will contribute towards the creation of European 
guidelines on the use of proton therapy for esophageal 
cancer. More information: https://protecttrial.eu/
340,000 patients treated with PT worldwide 
at the end of 20232
340,000 patients
Protect, enhance and save 
lives by contributing to 
MORE TARGETED TREATMENTS
Proton therapy is one of the most advanced forms 
of radiation therap